Following the American Society of Neuroradiology meeting, MedPage Today convened three leaders in neuro-oncology and brain tumor imaging for a virtual roundtable discussion on the evolving role of advanced MRI in brain tumor care. Moderator Suyash Mohan, MD, of the University of Pennsylvania in Philadelphia, is joined by Caroline Chung, MD, of the University of Texas MD Anderson Cancer Center in Houston, and Steven Brem, MD, also of the University of Pennsylvania.
In this fourth and final episode, the panel looks ahead to the future of brain tumor imaging, discussing how quantitative imaging biomarkers, artificial intelligence (AI), and public-private collaboration could advance precision neuro-oncology. The experts also consider what evidence will be needed before AI-derived imaging signatures can be trusted to guide real-world clinical decisions.
You can view the full series here.
Following is a transcript of their remarks:
Mohan: Now, since we are coming to the end of this session, I'd like to ask a little bit about the future in terms of quantitative biomarkers and artificial intelligence.
